APIs per la ricerca e le impurità

Mometasone Furoate EP Impurity J is a natural, non-synthetic impurity found in the drug product Mometasone Furoate EP. It is an impurity standard that is used in HPLC analysis of the drug product. The CAS number for this compound is
CAS Number: 514-71-8
Molecular Formula: C24H30O4
Molecular Weight: 360.48
Synonyms: Mometasone Furoate EP Impurity J;5α-pregna-1,4-diene-3,20 dione, 16-[(6-chloro-3-pyridinyl)oxy]-11β,17α,21-(epoxy)-
Impurity Standard for Mometasone Furoate EP

aR453588 is a human analog of Voriconazole, which has been found to have anticancer properties. This compound is a kinase inhibitor that works by inducing apoptosis in cancer cells. It has been shown to be effective against various types of tumors, including those resistant to other inhibitors. aR453588 also inhibits the growth of cancer cells by blocking protein synthesis and cell division. This compound is derived from cellulose and can be detected in urine samples after administration. Overall, aR453588 shows great promise as a potential treatment for cancer.

1-Methoxy amiodarone is a drug product that is a custom synthesis. It has CAS No. 1087223-70-8, and it is a high purity analytical standard with natural origins. Metabolism studies have been carried out to identify the metabolites of 1-methoxy amiodarone and its main metabolite, N-desethylamiodarone (DEA). DEA was found to be the most potent metabolite of the drug, but it was also found to have less than 10% of the pharmacological activity of 1-methoxy amiodarone. Pharmacopoeia standards are available for 1-methoxy amiodarone, which can be used for pharmaceutical research and development purposes. HPLC standards are also available for this compound.

GSK-2793660 is a potent and selective analog of a human protein kinase inhibitor that has been shown to induce apoptosis in cancer cells. It is a medicinal compound that inhibits the activity of kinases, which are enzymes involved in cell signaling pathways. GSK-2793660 has demonstrated anticancer activity in preclinical studies, particularly against Chinese hamster ovary (CHO) tumor models. This inhibitor has also been found in urine samples from cancer patients, indicating its potential as a diagnostic tool for cancer. Its ability to selectively target specific kinases makes it a promising candidate for the development of new cancer therapies.

4-Chloro-3-hydroxybutyric acid (4C3HB) is an analytical, research and development, high purity, synthetic, API impurity and HPLC standard. 4C3HB is a metabolite of the drug clofibric acid. It also serves as an impurity standard for clofibric acid. 4C3HB has been used in the synthesis of some drugs such as risperidone and carbamazepine. The chemical formula for 4C3HB is C9H13ClO2. CAS No. 95574-97-3

Rabeprazole Impurity 2 is a research and development impurity standard that is used for qualitative analysis. It can be custom synthesized to meet specific needs, and it can also be used in drug product synthesis. Rabeprazole Impurity 2 is a high purity synthetic compound that has been pharmacopoeia-qualified. It can also be used as a metabolite or analytical standard, and it has been studied for its metabolism studies with HPLC-MS. Rabeprazole Impurity 2 has CAS No. 1807988-36-8.

6-Iodo-2-propoxy-3-propylquinazolin-4(3H)-one is a potent anticancer agent that inhibits the activity of specific kinases involved in cancer cell growth and proliferation. It has been shown to induce apoptosis, or programmed cell death, in cancer cells by blocking the activity of certain proteins. This compound is structurally similar to other kinase inhibitors used in medicinal chemistry, such as gefitinib and erlotinib. 6-Iodo-2-propoxy-3-propylquinazolin-4(3H)-one has been tested on human and Chinese hamster ovarian cells and has demonstrated significant antitumor activity. It is a promising candidate for the development of new cancer therapies due to its potent inhibitory effects on kinases involved in tumor growth and progression. Additionally, this chemical analog can be detected in urine samples, making it a useful tool for studying kinase activities in vivo.

Naftifine-d3 is an analytical standard for HPLC. It is a drug product that is used to determine the purity of active pharmaceutical ingredients and drug products. Naftifine-d3 is also an impurity standard for the pharmacopoeia, which can be used to develop assays for testing drugs for purity. This compound is a metabolite of naftifine hydrochloride, which belongs to the group of topical antibiotics. Naftifine-d3 has been found in natural sources such as plants and fungi. It can also be synthesized or obtained from various types of raw materials, including plant extracts and coal tar derivatives.

Please enquire for more information about 2,3-Diphospho-D-glyceric acid pentasodium including the price, delivery time and more detailed product information at the technical inquiry form on this page

Carbocisteine is a drug that belongs to the class of non-steroidal anti-inflammatory drugs. It is used in the treatment of bronchial asthma, bronchitis, and chronic obstructive pulmonary disease. Carbocisteine has been shown to inhibit platelet aggregation and to reduce blood viscosity. Carbocisteine may also be classified as a drug that binds to octadecyl groups. In this way it can be used as an analytical reagent for substances with similar chemical structures.

7-O-(Triethylsilyl) paclitaxel is a synthetic Taxol analog. It is manufactured by custom synthesis and purified by HPLC to be used as an analytical standard for the determination of natural Taxol impurities in drug products.

4’-Chloro clomiphene citrate is a drug product that is used as an analytical standard and impurity in the pharmaceutical industry. This compound is a natural metabolite of clomiphene, and is found in urine, serum, liver, and brain tissue. 4’-Chloro clomiphene citrate has been shown to have anti-inflammatory properties.

Please enquire for more information about N,N-Bis(2-chloroethyl)-4-methoxybenzenesulfonamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

2,2',3,4,4',5-Hexachlorobiphenyl is a potent inhibitor of cancer cell growth and has been shown to induce apoptosis in Chinese hamster ovary cells. This compound also inhibits the activity of kinase inhibitors such as chloroquine and artesunate. It has been found in human urine samples and may be involved in the development of cancer. 2,2',3,4,4',5-Hexachlorobiphenyl has been identified as an analog of tumor-promoting compounds and may have potential as an anticancer agent. Further research is needed to fully understand its mechanism of action and potential therapeutic applications.

D-Ribose-L-cysteine is a combination of D-ribose and L-cysteine. It is used for the treatment of bowel disease, radiation injury, pentobarbital sodium induced ileus, atherosclerotic lesion, oral hypoglycaemic, neuronal death, psychotic disorder in AIDS patients and active antiretroviral therapy. D-Ribose-L-cysteine has been shown to decrease ATP levels and increase histological damage in v79 cells. D-Ribose-L-cysteine has also been shown to have a protective effect on hamster V79 cells against inflammatory bowel disease by decreasing the release of inflammatory cytokines.

2,2',3,3'-Tetrachlorobiphenyl is an inhibitor that has been shown to have anticancer properties. It inhibits the growth of tumor cells by blocking the activity of protein kinases, which are enzymes that regulate cell division and proliferation. This compound has been tested in Chinese hamster ovary cells and has been found to induce apoptosis in cancer cells. Additionally, 2,2',3,3'-Tetrachlorobiphenyl has analog inhibitors that have been tested in human urine samples and have shown potential as anticancer agents. These analogs inhibit cyclin-dependent kinases (CDKs), which play a crucial role in regulating the cell cycle. The inhibition of CDKs leads to the suppression of cancer cell growth and division, making this compound a promising candidate for future cancer treatments.

Granisetron is a drug that belongs to the group of serotonin receptor antagonists. It is used as an antiemetic, mainly in the prevention and treatment of nausea and vomiting caused by cancer chemotherapy and surgery. This drug has been shown to be effective in controlling nausea and vomiting, even when given after chemotherapy or surgical procedures. Granisetron hydrochloride was synthesized in 1988 by chemists at Hoffmann-La Roche. The synthesis was patented in 1990. Potential impurities are not listed on the USP or EP pharmacopeia, but these impurities have been detected during synthesis.

Please enquire for more information about (3S,4R)-3-Methyl-4-phenylpiperidine-4-carboxylic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

Remdesivir impurity 8 is a metabolite of remdesivir, a drug product that belongs to the class of synthetic compounds. Remdesivir impurity 8 has been used as a research and development standard for HPLC analysis. It is also used as an impurity standard in pharmacopoeia and drug development. This impurity has shown natural activity in metabolism studies, but it is not known if this activity is due to the compound itself or an artifact from its synthesis.

Piquindone is a medicinal compound that has shown promising anticancer properties in human tumor cells. It acts as an inhibitor of protein kinases, which are enzymes that regulate cell growth and division. Piquindone is an analog of a natural product found in Chinese urine and has been studied for its ability to induce apoptosis, or programmed cell death, in cancer cells. This compound has shown potent activity against various types of cancer cells and may have potential as a therapeutic agent for the treatment of cancer. Its mechanism of action involves the inhibition of specific kinases involved in cancer cell proliferation and survival. Piquindone is being investigated further for its potential as a cancer cell inhibitor.

Polyethylene glycol monoisotridecyl ether (PEG-DTAE) is a polymer that can be used as an antimicrobial agent. It is active against Gram-positive bacteria but not against Gram-negative bacteria. PEG-DTAE has anti-angiogenic effects, which may be due to its ability to inhibit the growth of new blood vessels and thereby prevent the spread of infection. In vitro assays have shown that PEG-DTAE can induce cell lysis and hemolysis in test samples. PEG-DTAE has been shown to have hemolytic activity in vivo in rats, with histology sections showing inflammation and necrosis in the spleen and liver. This polymer also causes symptoms such as fever, chills, rigors, and hypotension in patients with chronic renal failure who are undergoing dialysis.

Impurity F is a metabolite of Fexofenadine. It is an impurity that can be found in the drug product and is used as a research and development standard for impurities. Impurity F has been shown to be a metabolite of Fexofenadine in human liver microsomes, and this metabolite has also been shown to have antihistamine properties. This impurity is used as a pharmacopoeia reference standard for HPLC analysis of fluoroquinolones, but it does not have any therapeutic value.

Everolimus related compound 3 is a chemical compound that contains xylose, chamomile extract, cellulose, sulfadiazine, and other ingredients. It is commonly used in industrial applications and has various properties and uses. This compound has been found to have interactions with glutamate, basic proteins, tocopherol, biomass, ticagrelor, chemokines, P. aeruginosa, and other substances. It may also contain impurities such as growth factors and fatty acids. Its specific applications and benefits will depend on the intended use in different industries.

1,3-Bis(9H-carbazol-4-yloxy)-2-propanol is a metabolite of carvedilol. It is not active as a drug, but may have pharmacological effects. 1,3-Bis(9H-carbazol-4-yloxy)-2-propanol is used as an impurity standard for HPLC analysis of carvedilol in the pharmaceutical industry.

Please enquire for more information about DM3-SMe including the price, delivery time and more detailed product information at the technical inquiry form on this page

2S-OMPT is a protein that is expressed in the cell. It is involved in transcriptional regulation, and can be assayed using k562 cells. 2S-OMPT has been shown to be associated with cancer. It also increases resistance to chemotherapeutic agents by inhibiting cation channels or inducing apoptosis of leukemia cells. 2S-OMPT may also play an important role in intracellular calcium ion concentrations, as it binds to the extracellular domain of sphingosine kinase and inhibits its activity. This inhibition leads to decreased levels of intracellular calcium ions, which may modulate chemokine production by chemoresistant cancer cells.